These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 273802)

  • 1. Clinical use of plasma renin assays.
    Espiner EA; Donald RA; Miles K
    N Z Med J; 1978 Feb; 87(605):82-6. PubMed ID: 273802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of the plasma renin activity and aldosterone after salt restriction and upright posture in essential hypertension].
    Kokot F; Kuska J; Chorqzy M
    Z Gesamte Inn Med; 1976 Dec; 31(24):1016-20. PubMed ID: 1020406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma renin activity and aldosterone in patients with essential hypertension].
    Suchmanová I; Pjescák M; Kron I; Tkácová R; Grejtovská B; Machánová Y
    Vnitr Lek; 1990 Sep; 36(9):853-9. PubMed ID: 2251771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin-aldosterone system in arterial hypertension.
    Horký K; Gregorová I
    Cor Vasa; 1980; 22(1-2):59-73. PubMed ID: 6995018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension.
    Chobanian AV; Gavras H; Melby JC; Gavras I; Jick H
    Trans Assoc Am Physicians; 1978; 91():368-80. PubMed ID: 754399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism.
    Bernini G; Moretti A; Orlandini C; Berti P; Miccoli P; Bardini M; Taurino C; Bernini M; Salvetti A
    J Hypertens; 2008 May; 26(5):981-8. PubMed ID: 18398341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The importance of studying the renin-angiotensin-aldosterone system in essential arterial hypertension in clinical practice. Activity of the renin-angiotensin-aldosterone system during treatment of hypertension with ACE-inhibitors and beta blockers].
    Hrnciar J; Hrnciarová M; Lepej J; Okálová D; Kreze A; Chamulová M
    Vnitr Lek; 1994 Sep; 40(9):557-62. PubMed ID: 7975357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
    Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blunted suppression of plasma renin activity in diabetes.
    Gordon MS; Price DA; Hollenberg NK
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):252-6. PubMed ID: 11881033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
    Skrabal F; Mauser R
    Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.
    Hiramatsu K; Yamada T; Yukimura Y; Komiya I; Ichikawa K; Ishihara M; Nagata H; Izumiyama T
    Arch Intern Med; 1981 Nov; 141(12):1589-93. PubMed ID: 7030245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.
    Collins RD; Weinberger MH; Dowdy AJ; Nokes GW; Gonzales CM; Luetscher JA
    J Clin Invest; 1970 Jul; 49(7):1415-26. PubMed ID: 4317384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The integrated concentration of plasma renin activity and aldosterone in essential hypertension.
    Kowarski AA; Edwin CM; Akesode AP; Piotrowski LS; Hamilton BP
    Johns Hopkins Med J; 1978 Feb; 142(2):35-8. PubMed ID: 625094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of diazoxide on blood pressure, PRA and plasma aldosterone in hypertensive patients (author's transl)].
    Mantero F; Perini A; Armanini D; Gion M; Opocher G; Boscaro M
    G Ital Cardiol; 1976; 6(7):1246-53. PubMed ID: 1010235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and the renin-aldosterone system.
    Noth RH; Lassman MN; Tan SY; Fernandez-Cruz A; Mulrow PJ
    Arch Intern Med; 1977 Oct; 137(10):1414-7. PubMed ID: 921422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.